Galactan Biosynthesis in Mycobacterium tuberculosis
Open Access
- 1 July 2001
- journal article
- Published by Elsevier
- Vol. 276 (28) , 26430-26440
- https://doi.org/10.1074/jbc.m102022200
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosisMolecular Microbiology, 2000
- Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes inMycobacterium tuberculosisJournal of Biological Chemistry, 2000
- Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by IsoniazidScience, 1998
- New horizons in the treatment of tuberculosisBiochemical Pharmacology, 1997
- PROSPECTS FOR NEW INTERVENTIONS IN THE TREATMENT AND PREVENTION OF MYCOBACTERIAL DISEASEAnnual Review of Microbiology, 1995
- A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopyBiochemistry, 1995
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992
- Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurumAntimicrobial Agents and Chemotherapy, 1991
- Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 1979